Sales and Marketing

Showing 15 posts of 11520 posts found.

Catalent to purchase Italy manufacturing facility from BMS

June 20, 2019 Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, Cataletnt, pharma

Bristol-Myers Squibb has reached an agreement with Catalent for the latter to acquire its Anagni, Italy-based facility which specialises in …
28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019 Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …
merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019 Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
lynparza

EU approval for MSD and AZ’s Lynparza in first-line BRCA-mutated advanced ovarian cancer

June 18, 2019 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …

Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours

June 18, 2019 Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma

Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

Boehringer Ingelheim open new plant in Catalonia

June 17, 2019 Sales and Marketing Boehringer Ingelheim, Catalonia, Sant Cugat de Valles, barcelona, pharma

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona. The new …
facilities_lg06

Dr Reddy’s sells of two migraine treatments to Upsher-Smith Laboratories in deal worth $110 million

June 17, 2019 Sales and Marketing

Indian firm Dr Reddy’s has agreed to sell two migraine treatments to American firm Upsher-Smith Laboratories in a deal worth …
image_credit_united_states_mission_geneva

WHO decide not to declare global emergency

June 17, 2019 Sales and Marketing Ebola, UN, WHO, global emergency, health, pharma

The WHO has decided not to declare the Ebola crisis in the Congo a global emergency. While the WHO said …
29496564944_a9faceb1c2_z

Drugmakers sue Trump over prices in TV ads

June 17, 2019 Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …
16578744517_ed4293d3e7_z

Patient dies after receiving faecal transplant

June 17, 2019 Sales and Marketing Adverse Event, E.Coli. AMR, FDA, faecal transplant, pharma

A person has died after experiencing an adverse event related to a faecal transplant. The FDA has warned that two …
millerblockchainadj-1600x1200

The missing link: Blockchain in clinical data management

June 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, blockchain, data, data management, pharma, supply chain

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma

Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …
dr_aiden_cottrell

GSK tech exec joins Institute of Cancer Research

June 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information …
cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …
The Gateway to Local Adoption Series

Latest content